These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7543204)

  • 1. Design of four-helix bundle protein as a candidate for HIV vaccine.
    Eroshkin AM; Karginova EA; Gileva IP; Lomakin AS; Lebedev LR; Kamyinina TP; Pereboev AV; Ignat'ev GM
    Protein Eng; 1995 Feb; 8(2):167-73. PubMed ID: 7543204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Design of four-helix protein--a possible vaccine against human immunodeficiency virus (HIV-1)].
    Eroshkin AM; Zhilkin PA; Shamin VV
    Mol Biol (Mosk); 1993; 27(3):538-51. PubMed ID: 7686249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial protein vaccines with predetermined tertiary structure: application to anti-HIV-1 vaccine design.
    Eroshkin AM; Zhilkin PA; Shamin VV; Korolev S; Fedorov BB
    Protein Eng; 1993 Nov; 6(8):997-1001. PubMed ID: 7508628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of immunogens as components of a new generation of molecular vaccines.
    Loktev VB; Ilyichev AA; Eroshkin AM; Karpenko LI; Pokrovsky AG; Pereboev AV; Svyatchenko VA; Ignat'ev GM; Smolina MI; Melamed NV; Lebedeva CD; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):129-37. PubMed ID: 8717396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Construction and study of antigenic characteristics of recombinant salmonella strain producing TBI protein].
    Karpenko LI; Ignat'ev GM; Agafonov AP; Poryvaeva VA; Lebedev LP; Veremeĭko TA; Nekrasova NA; Klimov NA; Kozlov AP; Il'ichev AA
    Vopr Virusol; 2002; 47(2):25-8. PubMed ID: 12046463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.
    Bazhan SI; Belavin PA; Seregin SV; Danilyuk NK; Babkina IN; Karpenko LI; Nekrasova NA; Lebedev LR; Ignatyev GM; Agafonov AP; Poryvaeva VA; Aborneva IV; Ilyichev AA
    Vaccine; 2004 Apr; 22(13-14):1672-82. PubMed ID: 15068850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
    Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
    J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters.
    Azizi A; Anderson DE; Ghorbani M; Gee K; Diaz-Mitoma F
    BMC Immunol; 2006 Oct; 7():25. PubMed ID: 17076905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level expression, purification and characterization of recombinant CCR5 as a vaccine candidate against HIV.
    Wu K; Xue X; Li M; Qin X; Zhang C; Li W; Hao Q; Wang Z; Liu Q; Zhang W; Zhang Y
    Protein Expr Purif; 2013 Jun; 89(2):124-30. PubMed ID: 23542826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
    Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.
    Van Regenmortel MH
    Arch Virol; 2012 Jan; 157(1):1-20. PubMed ID: 22012269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synergistic effect of a combined bivalent DNA-protein anti-HIV-1 vaccine containing multiple T- and B-cell epitopes of HIV-1 proteins.
    Bazhan SI; Karpenko LI; Lebedev LR; Uzhachenko RV; Belavin PA; Eroshkin AM; Ilyichev AA
    Mol Immunol; 2008 Feb; 45(3):661-9. PubMed ID: 17869341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection.
    Yang Y; Zhu Q; Sun W; Guo J; Ning X; Li Q; Guo Y; Li J; Kou Z; Zhou Y
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-9. PubMed ID: 28281860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12.
    Karpenko LI; Scherbakova NS; Chikaev AN; Tumanova OY; Lebedev LR; Shalamova LA; Pyankova OG; Ryzhikov AB; Ilyichev AA
    Mol Immunol; 2012 Apr; 50(4):193-9. PubMed ID: 22341130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine.
    Wahome N; Pfeiffer T; Ambiel I; Yang Y; Keppler OT; Bosch V; Burkhard P
    Chem Biol Drug Des; 2012 Sep; 80(3):349-57. PubMed ID: 22650354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine.
    Yan J; Yoon H; Kumar S; Ramanathan MP; Corbitt N; Kutzler M; Dai A; Boyer JD; Weiner DB
    Mol Ther; 2007 Feb; 15(2):411-21. PubMed ID: 17235321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
    Jiang X; Totrov M; Li W; Sampson JM; Williams C; Lu H; Wu X; Lu S; Wang S; Zolla-Pazner S; Kong XP
    J Virol; 2016 Dec; 90(24):11007-11019. PubMed ID: 27707920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.